The EMA’s human medicines committee has recommended approval of a fixed-dose combination of Roche’s breast cancer drugs Herceptin and Perjeta – part of the company’s defense against ...

Glofitamab is a bispecific CD20-directed CD3 T-cell engager approved under the brand name Columvi ® for the treatment of adults with R/R DLBCL, not otherwise specified or large B-cell lymphoma arising ...

Planned for September 2025, the iPhone 17 models could feature larger display sizes, ProMotion across the lineup, Wi-Fi 7, and more.

Find the latest Alto Neuroscience, Inc. (ANRO) stock quote, history, news and other vital information to help you with your stock trading and investing.